Stay updated on Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial page.

Latest updates to the Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial page
- Check6 days agoChange DetectedThe Record History now shows an added Revision: v3.3.4 and the previous Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.3.3 has been added; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed, indicating minor maintenance to the history page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page history shows an internal revision update from v3.2.0 to v3.3.2, with no changes to study data or public content; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved the temporary government funding operating status notice from the page. All other record history content remains unchanged.SummaryDifference0.8%

- Check77 days agoChange DetectedVersion 2 (2023-11-28) updated the record to show Recruitment Status and Study Status, indicating the current enrollment status and overall trial status.SummaryDifference0.1%

- Check106 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference13%

Stay in the know with updates to Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial page.